Provision of Laboratory Services to Support the Delivery of the HPV Primary Screening Pathway within the NHS Cervical Screening Programme - East Midlands

Description

The aim of the NHS CSP is to reduce the incidence of, and mortality from, cervical cancer by delivering a systematic quality assured population-based screening programme for eligible people. The aim of the Service is to support the delivery of the NHS CSP by testing samples and making direct referrals to colposcopy. Lot 1: The aim of the NHS CSP is to reduce the incidence of, and mortality from, cervical cancer by delivering a systematic quality assured population-based screening programme for eligible people. The aim of the Service is to support the delivery of the NHS CSP by testing samples and making direct referrals to colposcopy. The relevant authority intends to award a contract to an existing provider under Direct Award C under the Health Care Services (Provider Selection Regime) regulations 2023. The contract value is £16,396,369 Contract Start Date: 01 July 2026 Contract End Date: 31 March 2029 The contract term is for an initial period of 21 months, with an option to extend for a further 12 months at the discretion of the Relevant Authority and subject to satisfactory contractual and financial performance. Additional information: Contract Value is based on annual FYE of £5,962,316. This is annual value equitable to that of current contract (2025/26 value), plus agreed annual population growth of 0.7%, 1.25% fixed payment and national CUF/inflators to be applied once published. Any additional services (eg HPV self sampling) to require additional negotiation. Value of +1 extension to be negotiated/agreed in-year, if enacted.